-
-
-
-
-
-
-
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
-
-
-
-
-
-
-
Merck beats estimates on strong oncology sales; shares up 4% in pre-market trade
-
-
-
-
-
-
-
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.
-
-
-
-
-
-
-
H.C. Wainwright Downgrades Terns Pharmaceuticals (TERN) to Neutral
-
-
-
-
-
-
-
RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
-
-
-
-
-
-
-
Merck ends acquisition talks with Revolution Medicines - WSJ
-
-
-
-
-
-
-
Merck Recommends Rejection of Tutanota’s “Mini-Tender” Offer
-
1,161,001 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

